Read more
A group of secondary plant metabolites known as flavonoids, which are polyphenolic chemicals, have a variety of pharmacological properties, including anti-cancer properties. By modifying various enzymes and receptors in signal transduction pathways related to cellular proliferation, differentiation, apoptosis, inflammation, angiogenesis, metastasis, and reversal of multi-drug resistance, they have been reported to interfere with the beginning, promoting, and progression of cancer. Flavonoids are being researched for their possible using cancer treatments due to their numerous molecular modes of action. By offering fresh perspectives on the variables, regulation, and molecular mechanisms as well as their major protein interactions, the book highlights the therapeutic of nano-encapsulation flavonoids and their synthetic analogs as anti-cancer medicines.
About the author
Dr. M. Rajasekar arbeitet seit 2018 als Assistenzprofessor (Forschung) im Zentrum für molekulare und nanomedizinische Wissenschaften, Internationales Forschungszentrum, Sathyabama Institute of Science and Technology (Deemed to be University), Chennai, Tamilnadu. Er wurde mit NPDF, DSKPDF, Nehru PDF und Young Scientist ausgezeichnet.
